맘모그래피 기기 - 세계 시장 인사이트, 경쟁 상황 및 시장 예측(2030년)

MAMMOGRAPHY DEVICES MARKET BY DEVICE TYPE (ANALOG, DIGITAL [FULL FIELD DIGITAL MAMMOGRAPHY, BREAST TOMOSYNTHESIS, AND COMBINATION SYSTEMS], AND OTHERS), BY END USER (HOSPITALS, SPECIALTY CLINICS, AND DIAGNOSTIC CENTERS), BY GEOGRAPHY IS EXPECTED TO GROW AT A STEADY CAGR (FORECAST PERIOD-2024-2030) OWING TO RISING TECHNOLOGICAL ADVANCEMENTS AND INCREASING PREVALENCE OF BREAST CANCER

Global Mammography Devices Market was valued at USD 1.78 billion in 2020, growing at a CAGR of 9.15% during the forecast period from 2024 to 2030, to reach USD 3.65 billion by 2030. The demand for Mammography Devices is primarily witnessing growth on account of the increasing prevalence of breast cancer, technological advancements in breast imaging, and increasing focus on creating awareness regarding routine breast cancer screening programs.

MAMMOGRAPHY DEVICES MARKET DYNAMICS:

According to the Centers for Disease Control and Prevention (CDC) reports 2018, breast cancer is one of the most common cancers among women, irrespective of race or ethnicity. It is also the third-most-common cause of death from cancer among American Indian/Alaska Native women.

As per a report published by Globocan in 2020, breast cancer was the most prevalent type of cancer exhibiting an 11.7% prevalence rate. The five-year prevalence rate for both the genders showed Asia to hold the highest number of affected people at 3,218,496 (41.3%), followed by Europe at 2,138,117 (27.4%) and North America with 1,189,111 people (15.3%). Such high prevalence rate of breast cancer across the globe is one of the key driving factors for the growth of the mammography devices market.

In addition to the abovementioned factors, the global population is aging, and age is considered to be a risk factor associated with breast cancer. It has been reported that women aged 60 years and above account for almost 78% of all breast cancer-related deaths. As breast cancer can be invasive in nature, early diagnosis along with routine checkups across becomes important for women across different age groups. This is further expected to boost the mammography devices market for in the forecast period as the market recovers from the effects of COVID-19.

However, stringent product approval process, adverse effects from radiation exposure and risks associated with mammography and high cost of mammograms are expected to limit the mammography devices market growth over the forecast period.

MAMMOGRAPHY DEVICES MARKET SEGMENT ANALYSIS:

Mammography Devices by Device Type (Analog, Digital [Full Field Systems and Breast Tomosynthesis Systems, and Combination Systems], and Others), Mammography Devices by End User (Hospitals, Specialty Clinics, and Diagnostic Centers), and Mammography Devices by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Mammography Devices market in the device type segment, the digital mammography segment is expected to amass the larger market share during the forecast period. Digital mammography is a specialized and advanced form of mammography that makes use of digital computers and receptors instead of X-ray films to examine breast tissue for the presence of signs of cancer.

Technological advancements have led to the advent of digital mammography. Due to the advantages offered by these systems such superior depiction of low-contrast objects, improved diagnostic quality of images, wider dynamic change as an increasing number of healthcare facilities are shifting toward these newer systems. They also come with the additional feature of soft-copy image displays and soft-copy reading that can be easily shared across devices. These factors have made digital mammography a popular choice among healthcare providers. Furthermore, the added safety associated with the digital mammography systems over conventional systems considering radiation exposure is significantly lower.

Digital Mammography systems can further be sub-categorized into full field mammography systems as well as breast tomosynthesis systems, and combination systems.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL MAMMOGRAPHY DEVICES MARKET:

Among all the regions, North America is expected to account for the largest share in the mammography devices market. This can be attributed to the growing prevalence of breast cancer and the access to better healthcare infrastructure in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.

The North American mammography devices market is expected to witness growth due to organization of supportive programs regarding breast cancer education and awareness. One such program is conducted by the National Breast Cancer Foundation (NBCF). The organization provides breast cancer education and free mammograms to women in need. The organization conducts numerous programs such as Beyond The Shock, National Mammography Program, Breast Health Awareness, and Patient Navigation.

MAMMOGRAPHY DEVICES MARKET KEY PLAYERS:

Some of the key market players operating in the Mammography Devices market includes SternMed GmbH, FUJIFILM Corporation, Hologic Inc, Planmed OY, General Electric Company (GE Healthcare), Siemens Healthcare GmbH, Koninklijke Philips NV, DMS Group, IMS Giotto S.P.A, General Medical Merate S.p.A, Konica Minolta Inc, Lanmage, Carestream Health, MEDI-FUTURE Inc, Villa Sistemi Medicali Spa. and others.

RECENT DEVELOPMENTAL ACTIVITIES IN MAMMOGRAPHY DEVICES MARKET:

In June 2022, iCAD Inc received the CE Mark approval for their software-ProFound AI® Version 3.0 for Digital Breast Tomosynthesis (DBT). The latest version of this software the offers up to a 10% improvement in specificity performance while maintaining an industry-leading high sensitivity level simultaneously.

In December 2020, Hologic Inc received the product approval from US Food and Drug Administration their Company's Genius AI Detection technology, a new deep learning-based software. This software helps in the early detection of breast cancer when used with the Genius 3D Mammography exam, as Genius AI Detection software aids in the identification and early detection of breast cancer.

In March 2020, Therapixel received the US FDA approval for their MammoScreen which is a computer-assisted detection and diagnosis software. This software helps the clinicians in identifying relevant findings when used with compatible full-field digital mammography systems.

KEY TAKES AWAY FROM THE MAMMOGRAPHY DEVICES MARKET REPORT STUDY

• Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Mammography Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Mammography Devices Market.
• Various opportunities available for the other competitor in the Mammography Devices Market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current Global Mammography Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Global Mammography Devices market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS MAMMOGRAPHY DEVICES MARKET REPORT STUDY

• Mammography Devices providers
• Research organizations and consulting companies
• Mammography Devices-related organization, association, forum, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Mammography Devices
• Various End-users who want to know more about the Mammography Devices Market and latest technological developments in the Mammography Devices market.

FREQUENTLY ASKED QUESTIONS FOR MAMMOGRAPHY DEVICES MARKET:

What is a Mammography Device?

A mammography device is used in the development of a mammogram which provides insights about the breast tissue. The machine takes x-rays at doses lower than usual x-rays. Different types of mammography devices are available in the market now such as analog systems, full field digital mammography systems, and digital breast tomosynthesis.

What is the market for Global Mammography Devices?

Global Mammography Devices Market was valued at USD 1.78 billion in 2020, growing at a CAGR of 9.15% during the forecast period from 2024 to 2030, to reach USD 3.65 billion by 2030.

What are the drivers for Global Mammography Devices Market?

The major drivers of the global mammography devices market growth are rising technological advancements in product development, increasing prevalence of breast cancer, and increasing focus on creating awareness regarding routine breast cancer screening among people, especially women.

What are the key players operating in Global Mamography Devices Market?

Some of the major market players operating in the Mammography Devices market include SternMed GmbH, FUJIFILM Corporation, Hologic Inc, Planmed OY, General Electric Company (GE Healthcare), Siemens Healthcare GmbH, Koninklijke Philips NV, DMS Group, IMS Giotto S.P.A, General Medical Merate S.p.A, Konica Minolta Inc, Lanmage, Crestream Health, MEDI-FUTURE Inc, Villa Sistemi Medicali Spa. and others.

What regions has the highest share in Mammography Devices market?

North America is expected to dominate the overall Mammography Devices market during the forecast period, 2024 to 2030. This can be correlated to the growing prevalence of breast cancer and the access to better healthcare infrastructure in the region majorly in the US and Canada which are expected to be the major influencing factors in driving the overall growth of the mammography devices market over the forecast period.

Table of Contents

1. Mammography Devices Market Report Introduction

2. Mammography Devices Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment
• 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1 The United States
• 3.2 Europe
  • 3.2.1 Germany
  • 3.2.2 France
  • 3.2.3 Italy
  • 3.2.4 Spain
  • 3.2.5 U.K.
• 3.3 Japan

4. Mammography Devices Market Key Factors Analysis

• 4.1 Mammography Devices Market Drivers
  • 4.1.1 Increasing Prevalence of Breast Cancer
  • 4.1.2 Growing awareness Regarding Breast Cancer
  • 4.1.3 Technological Advancements in Breast Imaging
  • 4.1.4 Increased Risk of Breast Cancer with Age
• 4.2 Mammography Devices Market Restraints and Challenges
  • 4.2.1 High cost of Mammograms
  • 4.2.2 Risks Associated with Radiation Exposure
• 4.3 Mammography Devices Market Opportunities
  • 4.3.1 Increasing focus towards breast cancer in low- and middle-income countries

5. Mammography Devices Market Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Mammography Devices Market

7. Mammography Devices Market Layout

• 7.1 By Type of Devices
  • 7.1.1 Analog Mammography Devices
  • 7.1.2 Digital Mammography Devices
    • 7.1.2.1 Full Field Digital Mammography Devices
    • 7.1.2.2 Breast Tomosynthesis Devices
    • 7.1.2.3 Combination Systems
  • 7.1.3 Others
• 7.2 By End User
  • 7.2.1 Hospitals
  • 7.2.2 Specialty Clinics
  • 7.2.3 Diagnostic Centers
• 7.3 By Geography
  • 7.3.1 North America
    • 7.3.1.1 North America Mammography Devices Market, by Type of Devices
    • 7.3.1.2 North America Mammography Devices Market, by End User
    • 7.3.1.3 North America Mammography Devices Market, by Country
    • 7.3.1.3.1 United States
    • 7.3.1.3.2 Canada
    • 7.3.1.3.3 Mexico
  • 7.3.2 Europe
    • 7.3.2.1 Europe Mammography Devices Market, by Type of Devices
    • 7.3.2.2 Europe Mammography Devices Market, by End User
    • 7.3.2.3 Europe Mammography Devices Market, by Country
    • 7.3.2.3.1 France
    • 7.3.2.3.2 Germany
    • 7.3.2.3.3 United Kingdom
    • 7.3.2.3.4 Italy
    • 7.3.2.3.5 Spain
    • 7.3.2.3.6 Russia
    • 7.3.2.3.7 Rest of Europe
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Asia-Pacific Mammography Devices Market, by Type of Devices
    • 7.3.3.2 Asia-Pacific Mammography Devices Market, by End User
    • 7.3.3.3 Asia-Pacific Mammography Devices Market, by Country
    • 7.3.3.3.1 China
    • 7.3.3.3.2 Japan
    • 7.3.3.3.3 India
    • 7.3.3.3.4 Australia
    • 7.3.3.3.5 South Korea
    • 7.3.3.3.6 Rest of Asia Pacific
  • 7.3.4 Rest of the World (RoW)
    • 7.3.4.1 RoW Mammography Devices Market, by Type of Devices
    • 7.3.4.2 RoW Mammography Devices Market, by End User
    • 7.3.4.3 RoW Mammography Devices Market, by Region
    • 7.3.4.3.1 Middle East
    • 7.3.4.3.2 Africa
    • 7.3.4.3.3 South America

8. Mammography Devices Global Company Share Analysis - Key 3-5 Companies

9. Mammography Devices Company and Product Profiles

• 9.1 Planmed OY
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4 Product Listing
  • 9.1.5. Entropy
• 9.2 FUJIFILM Corporation
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4 Product Listing
  • 9.2.5. Entropy
• 9.3 Hologic Inc
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4 Product Listing
  • 9.3.5. Entropy
• 9.4 SternMed GmbH
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4 Product Listing
  • 9.4.5. Entropy
• 9.5 General Electric Company (GE Healthcare)
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4 Product Listing
  • 9.5.5. Entropy
• 9.6 Siemens Healthcare GmbH
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4 Product Listing
  • 9.6.5. Entropy
• 9.7 DMS Group
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4 Product Listing
  • 9.7.5. Entropy
• 9.8 Koninklijke Philips NV
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4 Product Listing
  • 9.8.5. Entropy
• 9.9 IMS Giotto S.P.A
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4 Product Listing
  • 9.9.5. Entropy
• 9.10 General Medical Merate S.p.A.
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4 Product Listing
  • 9.10.5. Entropy
• 9.11 Konica Minolta, Inc.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4 Product Listing
  • 9.11.5. Entropy
• 9.12 Lanmage
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4 Product Listing
  • 9.12.5. Entropy
• 9.13 Carestream Health
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4 Product Listing
  • 9.13.5. Entropy
• 9.14 MEDI-FUTURE, Inc
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4 Product Listing
  • 9.14.5. Entropy
• 9.15 Villa Sistemi Medicali Spa.
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4 Product Listing
  • 9.15.5. Entropy

10. PROJECT APPROACH

• 10.1 Secondary Sources
• 10.2 Primary Sources
• 10.3 Data Triangulation
• 10.4 Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight